LITMUS

Searching for effective ways to diagnose non-alcoholic fatty liver disease

Around 20 million people in Germany suffer from non-alcoholic fatty liver disease (NAFLD). It can cause severe inflammation, cirrhosis of the liver, and even cancer. At present, there is no simple technique to detect NAFLD reliably at an early stage. But this is essential for the development of appropriate new drugs and therapies. The LITMUS research project seeks to make a major contribution in this field: Involving an international consortium, with the Mainz University Medical Center being a key player, the LITMUS network is developing biomarkers that open up new horizons.

more ... >